The gold standard GLP-1 agonist for sustainable weight loss and metabolic health.
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has become the most prescribed weight loss medication in history. Clinic-administered semaglutide (compounded from 503A/503B pharmacies) offers significant advantages over commercial Ozempic/Wegovy in terms of cost, customization, and availability.
Before starting any Semaglutide protocol, ask these questions — the answers reveal a lot about the clinic's quality and approach.
The quality of Semaglutide depends entirely on where it's compounded. Ask every clinic whether they use a 503A or 503B FDA-registered compounding pharmacy. Learn the difference here →